Abstract Hot flashes (HF) are a common adverse event of prolonged tamoxifen use in women with estrogen receptor-positive breast cancer. impacting psychiatric health and quality of life. While desvenlafaxine does not interact with tamoxifen. its efficacy and safety in breast cancer patients remain unstudied. https://www.hindirochakkahaniya.com/